$EVT (+20,89 %)
$SVA (-0,32 %)

Evotec and Sernova enter into a worldwide exclusive strategic partnership in the field of iPSC-based beta cell replacement therapy to develop a funjtional cure for diabetes.

https://www.irw-press.com/de/news/sernova-und-evotec-gehen-weltweite-exklusive-strategische-partnerschaft-hinsichtlich-betazell-ersatztherapie-auf-ipsc-basis-ein-um-eine-funktionelle-heilung-fuer-diabetes-zu-entwickeln-und-zu-kommerzialisieren_65836.html?isin=CA81732W1041

I do not guarantee the completeness and/or accuracy of the news.

This is not an analgeberatung, investment recommendation or a call to action.